US Patent Issued to FUKUSHIMA MEDICAL UNIVERSITY on Dec. 9 for "Biomarker for predicting the prognosis for an endometrial cancer patient" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,493,039, issued on Dec. 9, was assigned to FUKUSHIMA MEDICAL UNIVERSITY (Fukushima, Japan).

"Biomarker for predicting the prognosis for an endometrial cancer patient" was invented by Hideki Chiba (Fukushima, Japan) and Kotaro Sugimoto (Fukushima, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An objective of the present invention is to provide a novel biomarker for predicting the prognosis of an endometrial cancer patient. A biomarker that comprises a claudin 6 protein or a peptide fragment thereof, or a transcription product of a claudin 6 gene or a nucleic acid fragment thereof is provided so as to predict the prognosis of an endometrial cancer p...